Belimumab 1 mg/kg + Belimumab 10 mg/kg
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
22
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Lupus Erythematosus, Discoid
Conditions
Lupus Erythematosus, Discoid
Trial Timeline
May 1, 2011 → Jun 1, 2011
NCT ID
NCT01858792About Belimumab 1 mg/kg + Belimumab 10 mg/kg
Belimumab 1 mg/kg + Belimumab 10 mg/kg is a pre-clinical stage product being developed by GSK plc for Lupus Erythematosus, Discoid. The current trial status is completed. This product is registered under clinical trial identifier NCT01858792. Target conditions include Lupus Erythematosus, Discoid.
Hype Score Breakdown
Clinical
5
Activity
2
Company
9
Novelty
2
Community
1
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01858792 | Pre-clinical | Completed |
| NCT00724867 | Phase 3 | Completed |
Competing Products
20 competing products in Lupus Erythematosus, Discoid